Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | PCRX | Common Stock | Options Exercise | $105K | +2K | +7.53% | $52.37 | 28.6K | May 23, 2022 | Direct | F1 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | PCRX | Stock Option (Right to Buy) | Options Exercise | $0 | -2K | -5.33% | $0.00 | 35.5K | May 23, 2022 | Common Stock | 2K | $52.37 | Direct | F2 |
Id | Content |
---|---|
F1 | Includes 209 shares of common stock acquired under the issuer's employee stock purchase plan in December 2021. |
F2 | The stock option vested and became exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date. |